Does NATALIZUMAB Cause Patent ductus arteriosus? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Patent ductus arteriosus have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.0% of all adverse event reports for NATALIZUMAB.
13
Reports of Patent ductus arteriosus with NATALIZUMAB
0.0%
of all NATALIZUMAB reports
4
Deaths
9
Hospitalizations
How Dangerous Is Patent ductus arteriosus From NATALIZUMAB?
Of the 13 reports, 4 (30.8%) resulted in death, 9 (69.2%) required hospitalization.
Is Patent ductus arteriosus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Patent ductus arteriosus?
ONDANSETRON (185)
LAMOTRIGINE (168)
PAROXETINE (168)
ACETAMINOPHEN (154)
VENLAFAXINE (135)
SERTRALINE (130)
LEVETIRACETAM (122)
FLUOXETINE (107)
METOPROLOL (104)
RAMIPRIL (98)
Which NATALIZUMAB Alternatives Have Lower Patent ductus arteriosus Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK